477 related articles for article (PubMed ID: 22045674)
21. Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis.
Ma YC; Yang JY; Yan LN
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1007-16. PubMed ID: 23478672
[TBL] [Abstract][Full Text] [Related]
22. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM
J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902
[TBL] [Abstract][Full Text] [Related]
23. Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.
Cai X; Zhai J; Kaplan DE; Zhang Y; Zhou L; Chen X; Qian G; Zhao Q; Li Y; Gao L; Cong W; Zhu M; Yan Z; Shi L; Wu D; Wei L; Shen F; Wu M
Hepatology; 2012 Nov; 56(5):1804-16. PubMed ID: 22684921
[TBL] [Abstract][Full Text] [Related]
24. The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.
Govaere O; Petz M; Wouters J; Vandewynckel YP; Scott EJ; Topal B; Nevens F; Verslype C; Anstee QM; Van Vlierberghe H; Mikulits W; Roskams T
Oncogene; 2017 Nov; 36(47):6605-6616. PubMed ID: 28783171
[TBL] [Abstract][Full Text] [Related]
25. Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.
Kim YJ; Rhee H; Yoo JE; Alves VAF; Kim GJ; Kim HM; Herman P; Chagas A; Kim H; Park YN
Histopathology; 2017 Aug; 71(2):217-226. PubMed ID: 28326574
[TBL] [Abstract][Full Text] [Related]
26. Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis.
Takano M; Shimada K; Fujii T; Morita K; Takeda M; Nakajima Y; Nonomura A; Konishi N; Obayashi C
BMC Cancer; 2016 Nov; 16(1):903. PubMed ID: 27863477
[TBL] [Abstract][Full Text] [Related]
27. Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma.
Sulpice L; Rayar M; Turlin B; Boucher E; Bellaud P; Desille M; Meunier B; Clément B; Boudjema K; Coulouarn C
J Surg Res; 2014 Nov; 192(1):117-23. PubMed ID: 24909871
[TBL] [Abstract][Full Text] [Related]
28. SOX9 Expression Is Superior to Other Stem Cell Markers K19 and EpCAM in Predicting Prognosis in Hepatocellular Carcinoma.
Ruzinova MB; Ma C; Brunt EM; Goss CW; Vachharajani N; Chapman WC; Liu TC
Am J Surg Pathol; 2023 Jan; 47(1):1-11. PubMed ID: 36322988
[TBL] [Abstract][Full Text] [Related]
29. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.
Karaosmanoğlu O; Banerjee S; Sivas H
Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.
Shibuya M; Kondo F; Sano K; Takada T; Asano T
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):537-43. PubMed ID: 21234612
[TBL] [Abstract][Full Text] [Related]
31. [Associations between interleukin-17A expression and epithelial-mesenchymal transition in patients with hepatocellular carcinoma].
Xu J; Wang J; Hu Y; Cheng L; Yu H
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):585-90. PubMed ID: 26714598
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi.
Yu XH; Xu LB; Liu C; Zhang R; Wang J
Dig Dis Sci; 2011 Jan; 56(1):252-9. PubMed ID: 20437099
[TBL] [Abstract][Full Text] [Related]
33. Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers.
Mitra A; Satelli A; Xia X; Cutrera J; Mishra L; Li S
Int J Cancer; 2015 Jul; 137(2):491-6. PubMed ID: 25487874
[TBL] [Abstract][Full Text] [Related]
34. SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis.
Park H; Lee H; Seo AN; Cho JY; Choi YR; Yoon YS; Han HS; Park YN; Kim H
J Pathol Transl Med; 2015 Sep; 49(5):373-81. PubMed ID: 26265684
[TBL] [Abstract][Full Text] [Related]
35. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
36. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma.
Sasaki A; Kamiyama T; Yokoo H; Nakanishi K; Kubota K; Haga H; Matsushita M; Ozaki M; Matsuno Y; Todo S
Oncol Rep; 2010 Aug; 24(2):537-46. PubMed ID: 20596644
[TBL] [Abstract][Full Text] [Related]
38. Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
Rhee H; Kim H; Park YN
Liver Cancer; 2020 Dec; 9(6):663-681. PubMed ID: 33442539
[TBL] [Abstract][Full Text] [Related]
39. Identification of keratin 19-positive cancer stem cells associating human hepatocellular carcinoma using CYFRA 21-1.
Kawai T; Yasuchika K; Ishii T; Katayama H; Yoshitoshi EY; Ogiso S; Minami T; Miyauchi Y; Kojima H; Yamaoka R; Kita S; Yasuda K; Sasaki N; Fukumitsu K; Hatano E; Uemoto S
Cancer Med; 2017 Nov; 6(11):2531-2540. PubMed ID: 28965351
[TBL] [Abstract][Full Text] [Related]
40. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]